جست‌وجوی استاد و پژوهشگر

• Pediatric Oncology
• Neurogenetics
• Molecular Pathology
• +۳ مورد دیگر

Casmir Turnquist is a Research Fellow at the Nuffield Department of Clinical Neurosciences, University of Oxford, with concurrent roles as an NIHR Academic Clinical Fellow and Specialty Registrar in Histopathology at OUH NHS Foundation Trust. His work bridges clinical practice and research in pediatric brain/spine cancers and neurodegenerative pathologies. BA, MSc, BM BCh, DPhil His research investigates fusion-driven cancers in young patients using long-read sequencing and single-cell genomics, alongside studying neurotoxicity from cancer therapies through spatial transcriptomics and developmental neuroscience perspectives. Recent work includes characterizing CLIPPERS inflammatory disorders and SLONM myopathy. Publications demonstrate expertise in CNS tumors, inflammatory pathologies, and digital pathology implementation, with methodological focus on genomic heterogeneity and precision diagnostics. NIH Director's Innovation Award Supervises DPhil students Hannah Brooks and Claire Lewis, maintaining collaborations with Oxford Brain Bank and NIH institutions while advancing translational research in neuro-oncology and neuropathology.

Chirag R. Patelمشاهده پروفایل

مدرس پزشکی

• Pathology
• Surgical Pathology
• Gastrointestinal Pathology
• +۴ مورد دیگر

Chirag R. Patel, M.D. , is a pathologist at Mayo Clinic in Phoenix, Arizona. His affiliations include the Laboratory Medicine and Pathology department, with specific expertise in Anatomic Pathology , GI/Hepatic Pathology , and Digital Pathology . Education: MD (2013), BA (2011), both from University of Missouri; Residency (2017) and Fellowship (2018) at University of Missouri and University of Alabama at Birmingham, respectively. Certifications: American Board of Pathology (Anatomic & Clinical Pathology 2017, Clinical Informatics 2022) Dr. Patel's research bridges gastrointestinal pathology , hepatic diseases , and digital pathology . His work includes applying artificial intelligence to quantitate steatosis in liver transplants, molecular characterization of low-grade dysplastic lesions in inflammatory bowel disease, and immunohistochemical studies in CK7 patterns for liver disease diagnosis. His publications highlight liver transplantation , colorectal cancer , and viral impacts on gastrointestinal organs . Recent publications reflect trends in digital pathology integration, AI-driven diagnosis , and complex liver/gastrointestinal disease mechanisms . His work on B3GNT6 as a ganglion cell marker for Hirschsprung's disease and videoconference microscopy for Barrett's esophagus evaluation demonstrates innovation in diagnostic approaches. 2018: Outstanding Research Presentation - Pathology Trainee Research Day, University of Alabama at Birmingham 2015: Outstanding Resident Award - Kansas City School of Medicine, University of Missouri 2010: Pledge of the Year - Alpha Phi Omega Service Fraternity, Hope College Dr. Patel actively leads initiatives in digital pathology and medical education , serving as Medical Director for Digital Pathology and Histology Lab at University of Alabama at Birmingham. His mentorship extends through roles in residency selection, clinical competency, and professional development committees. His lab and team collaborations focus on multidisciplinary pancreaticobiliary disease , GI working groups , and digital pathology associations , emphasizing cross-institutional research and education.

J. Quincy Brownمشاهده پروفایل

دانشیار

• Biomedical Engineering
• Cancer Diagnostics
• Biomedical Optics
• +۳ مورد دیگر

J. Quincy Brown is an Associate Professor in the Department of Biomedical Engineering at Tulane University's School of Science and Engineering. His laboratory focuses on developing translational optical spectroscopy and imaging methods for improving cancer management in clinical settings, particularly surgical tumor removal. Research emphasizes device development and clinical validation through physician collaborations. Education: Ph.D. Biomedical Engineering, Louisiana Tech University (2005) B.S. Biomedical Engineering, Louisiana Tech University (2001) Postdoctoral Fellow, Biomedical Engineering, Duke University (2009) Research spans quantitative spectroscopy, fluorescence histology, structured illumination microscopy, and real-time diagnostic platforms. Work integrates optical engineering with oncology to develop clinical tools for tumor margin assessment and rapid biopsy analysis through collaborations with surgical teams. Recent publications demonstrate focus on advanced microscopy platforms (2021-2025), including PathCAM for digital pathology, light sheet microscopy optimizations using deep learning, and clinical validation studies of structured illumination for breast/prostate cancer. Technical innovations prioritize clinical translation through closed-loop systems and workflow integration. Awards and Honors: NIH NRSA Postdoctoral Fellowship (2006) Duke Cancer Center Young Investigator Award (2007) 4× AEMB Teacher of the Year (2013-2019) OSA Biophotonics Congress Chair (2019) Y Combinator recognition for Instapath Inc (2019) Tulane University Research Achievement Award (2021) NIH Imaging Technology Development charter member (2021-27) School of Science and Engineering All-Around Award (2022) Leads courses in Biomedical Optics (BMEN 6170) and Biomedical Signals/Systems (BMEN 3730/6730). Collaborates with clinical partners to develop intraoperative imaging solutions and validate diagnostic platforms in surgical oncology workflows.

Chris Hartleyمشاهده پروفایل

پزشک-پژوهشگر

• Gastrointestinal Pathology
• Liver Pathology
• Cytopathology
• +۴ مورد دیگر

Chris Hartley, M.D. is a Physician Scientist at Mayo Clinic's Department of Laboratory Medicine and Pathology, specializing in gastrointestinal and liver pathology, cytopathology, and pancreatobiliary cytology. He completed his MD at Wake Forest University School of Medicine (2012) and fellowships at Washington University School of Medicine (2018) and University of Wisconsin Hospital (2017). 2018 Fellow - Liver and Gastrointestinal Pathology 2017 Fellow - Cytopathology 2016 Resident - Anatomic & Clinical Pathology Hartley's research integrates artificial intelligence with cytopathology and histopathology , focusing on improving diagnostic accuracy for pancreatic ductal adenocarcinoma, colonic graft-versus-host disease, and hepatocellular carcinoma. His work explores AI-driven tools for bile duct brushing evaluation and spatially resolved iron quantification in liver samples. Recent publications highlight his leadership in digital pathology and AI applications across gastrointestinal, hepatic, and pulmonary diseases. Key trends include: AI for histologic differentiation in cancers Cytomorphologic studies of rare neoplasms Molecular marker analysis in transplant-related pathologies Scientific recognitions include: 2019 'Good Catch' Patient Safety Award 2017 Young Investigator Award - Cancer Cytopathology 2015 USCAP Abstract Award Runner-up As a member of the Rodger C. Haggitt Gastrointestinal Pathology Society and American Society for Clinical Pathology, Hartley contributes to precision medicine initiatives and multidisciplinary cancer care teams.

Rumeal D. Whaleyمشاهده پروفایل

استادیار

• Pathology
• Genitourinary Pathology
• Head and Neck Pathology
• +۵ مورد دیگر

Rumeal D. Whaley, M.D. is a faculty member in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, Minnesota, specializing in Anatomic Pathology. He completed his medical training at University of Louisville and pursued fellowships in Genitourinary Pathology at Indiana University and Head and Neck Pathology at Cleveland Clinic. His educational background includes: 2022: Fellow - Genitourinary Pathology, Indiana University 2021: Fellow - Head and Neck Pathology, Cleveland Clinic 2020: Residency - Anatomic & Clinical Pathology, Indiana University School of Medicine 2016: MD - Distinction in Research, University of Louisville School of Medicine 2011: BA, University of Louisville Dr. Whaley's research focuses on specialized areas of pathology including genitourinary tumors, head and neck pathology, endocrine pathology, and molecular characterization of various neoplasms. His work frequently involves immunohistochemical analysis, molecular profiling, and the study of rare tumor entities. He has made significant contributions to understanding renal cell carcinomas, thyroid pathology, penile squamous cell carcinoma, and various rare tumor types through his extensive publication record. His research trends show a strong emphasis on molecular pathology techniques, biomarker discovery, and the characterization of rare tumor entities across multiple organ systems. Recent publications highlight his expertise in applying advanced genomic and immunohistochemical techniques to better classify and understand tumor behavior. Among his notable recognitions: 2025 UroToday "Beyond the Abstract" Feature 2022 Excellence in Research, Indiana University School of Medicine 2020 Best Resident Case Study Poster Finalist, American Society for Clinical Pathology 2020 Society of '67 Open Access Award, Association of Pathology Chairs 2019 Excellence in Pathology Resident Teaching, Indiana University Dr. Whaley serves on multiple professional committees including as an abstract reviewer for the American Society for Clinical Pathology and is actively involved in collaborative pathology initiatives between Mayo Clinic and other institutions. His professional memberships span numerous pathology organizations including the Endocrine Pathology Society, Minnesota Society of Pathologists, and the Society of Black Pathology. He participates in the ProMedica & Mayo Clinic-Anatomic Pathology ePath Live Collaboration and the Sanford & Mayo Clinic-Anatomic Pathology ePath Live Collaboration, demonstrating his engagement in innovative telepathology approaches and collaborative diagnostic practices.

• Personalized Medicine
• Breast Cancer
• Cancer Staging
• +۴ مورد دیگر

Anja Brügmann serves as a Chief Physician ( Cheflæge ) at Aalborg University Hospital within The Faculty of Medicine, specifically in the Department of Pathology. Her work bridges clinical pathology practice with cutting-edge cancer research, focusing on precision medicine applications for cancer patients. Her research interests center around Personalized Medicine , Breast Cancer , Cancer Staging , Targeted Therapy , and Digital Pathology . Dr. Brügmann's work demonstrates a strong commitment to improving cancer diagnostics and treatment through molecular approaches, with particular emphasis on translating research findings into clinical practice. Her fingerprint analysis shows strong connections to Personalized Medicine (100%), Breast Cancer (80%), Cancer Staging (80%), and Targeted Therapy (80%). Analysis of her publication record reveals a consistent research trajectory focused on precision oncology, with recent work examining the clinical impact of precision medicine for late-stage cancer patients and the validation of digital pathology techniques. Her 2025 publication on longer survival with precision medicine in late-stage cancer represents the cutting edge of her current research focus. Dr. Brügmann has made significant contributions to Danish cancer research infrastructure, including participation in major biobank studies that support health research in Denmark. Her work with the Danish Scientific Committee of Pathology and the Danish Breast Cancer Cooperative Group (DBCG) demonstrates her leadership in establishing standardized protocols for cancer diagnostics. Her research methodology spans from molecular studies of cancer biology to large-scale clinical implementation projects, reflecting a comprehensive approach to advancing cancer care through pathology innovation.

• Pathology
• Cytopathology
• Transfusion Medicine
• +۳ مورد دیگر

Dr. Kristin Stendahl is an Assistant Professor in the Department of Pathology and Laboratory Medicine at Yale School of Medicine, Yale University. She holds joint appointments in Laboratory Medicine and Pathology. Board-certified in Anatomic/Clinical Pathology and Cytopathology, with eligibility in Transfusion Medicine. Completed extensive training including MD (University of Minnesota), residency at Yale, and dual fellowships in Cytopathology and Blood Banking. Education: BS Chemical Engineering - University of Texas (2004) MD - University of Minnesota (2016) AP/CP Residency - Yale University (2020) Blood Bank Fellowship - Yale University (2021) Cytopathology Fellowship - Yale University (2022) Her research spans transfusion medicine complications, cytopathology of neoplasms, and laboratory informatics. Focus areas include apheresis therapies, transfusion reactions, cytomorphologic characterization of hepatobiliary/breast malignancies, and innovative laboratory consultation systems. Recent work explores Rh alloimmunization, hyperhemolysis in pregnancy, and diagnostic biomarkers. Publications demonstrate consistent focus on clinical pathology applications, with emphasis on transfusion safety, cytopathology diagnostics, and laboratory system innovations. Work frequently addresses complex interdisciplinary clinical scenarios requiring integrated pathology solutions. Currently mentors MD/MS resident Ujunwa Korie (2024-2025). Active contributor to academic literature with original research and book chapters in transfusion medicine.

Manuel Salto-Tellezمشاهده پروفایل

استاد بالینی

• Molecular Pathology
• Cancer Research
• Oncology
• +۵ مورد دیگر

Professor Manuel Salto-Tellez is Chair of Molecular Pathology at Queen’s University Belfast (QUB), Clinical Consultant Pathologist at the Belfast Health and Social Care Trust, and Deputy Director of the Centre for Cancer Research and Cell Biology (CCRCB). He holds dual roles in academia and clinical practice, with expertise spanning molecular diagnostics, cancer pathology, and translational research. Education: Earned Licenciado en Medicina y Cirugía (MD equivalent) from the University of Oviedo (Spain), followed by advanced training at RWTH Aachen (Germany), Leiden University (Netherlands), and the University of Edinburgh. Key qualifications include FRCPath (2006), FRCPI (2013), and certifications in molecular pathology. Research Focus: Specializes in molecular pathology’s role in personalized cancer care. Key themes include predictive biomarkers for colorectal cancer, integration of genomics with histopathology, and digital pathology workflows. His work contributes to UN Sustainable Development Goals (SDG 3: Good Health and Well-being). Grants & Funding: Secured £4.9M in active grants at QUB, including CR-UK Accelerator Awards and Movember Centre funding. Notable projects include the Future Medicines Institute (2024) and a Precision Medicine Centre of Excellence. Awards: Includes the 2005 World Scientists Forum Award for Onco-Cytology and recognition for leadership during the SARS crisis. Active in global committees like the National Cancer Research Institute’s Colorectal Group and Genomics England. Labs/Teams: Leads the Molecular Pathology Lab at QUB’s Future Medicines Institute. Collaborates internationally on projects like federated learning for cancer image analysis and KRAS mutation prediction frameworks.

• Hematopathology
• Molecular Diagnostics
• Myeloproliferative Neoplasms
• +۴ مورد دیگر

Cade D Arries serves as an Assistant Professor in the Department of Laboratory Medicine and Pathology at the University of Minnesota, where he focuses on advancing diagnostic pathology through research and innovation. His work bridges clinical practice, medical education, and global health initiatives with particular emphasis on hematopathology and molecular diagnostics. Dr. Arries' research interests center on improving diagnostic pathways for hematologic malignancies, particularly myeloproliferative neoplasms. He has developed molecular testing algorithms to enhance efficiency in JAK2, MPL, and CALR gene testing. A significant portion of his work involves international collaboration, especially with Vietnamese institutions, where he implements videoconferencing technology to improve diagnostic capabilities for rare conditions like T-cell large granular lymphocytic leukemia. His research also explores innovative medical education methods, including asynchronous video materials for peripheral blood smear education, and he maintains expertise in infectious disease pathology as demonstrated by his work on rare bacteremia cases. Analysis of Dr. Arries' publication trends reveals a strong commitment to making specialized pathology expertise accessible worldwide. His work consistently addresses diagnostic challenges in resource-limited settings while developing practical solutions for improving testing efficiency. The interdisciplinary nature of his research connects pathology with global health equity, medical education innovation, and health systems improvement, with publications spanning molecular diagnostics, telepathology, and rare infectious disease cases. Through extensive collaboration with colleagues at the University of Minnesota and international partners, particularly in Vietnam, Dr. Arries contributes significantly to advancing diagnostic medicine. His work on implementing WHO-HAEM5 classification through digital platforms demonstrates his dedication to standardizing diagnostic approaches globally. Dr. Arries' research directly supports UN Sustainable Development Goals related to good health and well-being by improving diagnostic accessibility and developing more efficient testing protocols for hematologic conditions.

• Pathology
• Melanoma Research
• Cancer Biology
• +۳ مورد دیگر

Jeffrey Mito, M.D., Ph.D., is an Assistant Professor of Pathology at Brigham and Women's Hospital . His work bridges pathology , oncology , and translational research , with a focus on molecular diagnostics and cancer biology. Research Interests : Melanoma pathogenesis, radiation-associated sarcomas, immunohistochemical markers, and clinical cytology. Key Collaborations : Leonard Zon, Jason Hornick, Edmund Cibas, Lynette Sholl, Vickie Jo, Andrew Miron. Mito’s publications reveal trends in diagnostic innovation , particularly for pancreatic ductal adenocarcinoma and neurofibromas , with emphasis on biomarker validation (e.g., MTAP, HMGA2) and NGS technologies . Recent work explores neural crest dynamics in melanoma and quality improvement in cytopathology. His scientific contributions include developing immunohistochemical panels for distinguishing pleomorphic adenomas and refining HPV triage protocols for cervical cancer screening. No awards or student advisees are documented in the provided data.

Mustafa Arainمشاهده پروفایل

استاد

• Gastroenterology
• Endoscopy
• Biliary Diseases
• +۳ مورد دیگر

Mustafa Arain, MD is a Professor at the University of California, San Francisco (UCSF). He specializes in gastroenterology and endoscopic interventions, with a focus on biliary diseases, ERCP techniques, and telemedicine applications in healthcare. His research explores procedural outcomes, post-surgical complications, and innovative diagnostic approaches. Education: He completed his medical degree at the United Medical & Dental Schools, Guy's and St Thomas' (2000), followed by residency and fellowships at the University of Minnesota Medical Center from 2006–2010. Research interests include optimizing ERCP utilization in pediatric and post-surgical populations, reducing readmission rates through timely interventions, and advancing telemedicine's role in gastroenterology. His work frequently addresses challenges in biliary access and stent management post-Whipple resections or gastric bypass surgeries. Recent studies highlight his contributions to endoscopic ultrasound (EUS) techniques for gallbladder drainage, telepathology integration in pancreatic lesion diagnosis, and comparative analyses of stent materials for benign biliary strictures. Despite his prolific publication record, no scientific awards are explicitly mentioned in the provided text. His work often involves collaborations with institutions globally, focusing on procedural standardization and patient outcome improvements.

Paula E Northمشاهده پروفایل

استاد

• Vascular Anomalies
• Pediatric Pathology
• Global Environmental Health
• +۳ مورد دیگر

Dr. Paula E North is a Professor of Pathology at the Medical College of Wisconsin with a secondary appointment in the MCW Institute for Health and Society. She serves as Department Chief for Children's Medical and Dental Staff in Pathology and Laboratory Medicine. Her clinical focus is in Pediatric Pathology at Children's Wisconsin. Dr. North founded the Children's Research Institute Histology Core in 2006, providing advanced histology services to researchers. Her research emphasizes vascular anomalies, pediatric molecular diagnostics, and global environmental health initiatives. Education: PhD in Molecular Biology (Vanderbilt University, 1982), MD (University of Arkansas for Medical Sciences, 1992), Anatomic & Clinical Pathology residency (UAMS, 1992-1995) Her research spans vascular tumors/malformations, telepathology-supported laboratory models in resource-limited settings, and cardiac pathology in post-COVID-19 patients. Recent publications highlight innovations in cell-free DNA thresholds for cardiac transplant monitoring and profibrotic mechanisms in viral myocardial injury. Dr. North’s contributions include pioneering diagnostic protocols for vascular anomalies and advancing sustainable telepathology systems globally. She holds board certifications in Pediatric Pathology and Anatomic & Clinical Pathology.

Vijaya B. Kolachalamaمشاهده پروفایل

دانشیار

• Computational Pathology
• Medical Imaging AI
• Digital Biomarkers
• +۱ مورد دیگر

Vijaya B. Kolachalama is Associate Professor at Boston University's Chobanian & Avedisian School of Medicine, with joint appointments in Computing & Data Sciences. His laboratory develops AI methodologies for medical image analysis and digital biomarker discovery. Research integrates deep learning with healthcare applications including computational pathology for kidney and lung diseases, multimodal Alzheimer's diagnosis, and privacy-preserving voice analysis for cognitive assessment. The team creates frameworks for tissue segmentation, digital histopathology, and disease progression modeling. Professor Kolachalama leads NIH-funded projects on digital cognitive assessment and dementia heterogeneity. He has developed platforms for real-time biopsy adequacy assessment and differential dementia diagnosis using multimodal data fusion. As a Fellow of the American Heart Association, he contributes to cardiovascular computational pathology initiatives. His group collaborates broadly on medical AI applications across neurology, nephrology, and oncology.

Catherine Abendrothمشاهده پروفایل

استاد

• Pathology
• Anatomic Pathology
• Biopsy Techniques
• +۳ مورد دیگر

Catherine Abendroth, MD is a Professor and Chief of the Division of Anatomic Pathology at the Penn State College of Medicine . She holds a faculty appointment in the Department of Pathology and Laboratory Medicine, with expertise in surgical pathology, cytopathology, and renal pathology. Her academic roles include clinical service leadership and medical education. Dr. Abendroth completed her medical degree at the University of Maryland School of Medicine (1984), followed by pathology residencies at Beth Israel Hospital-Harvard Medical School (1987-1988) and Milton S. Hershey Medical Center (1987). She also completed a surgical pathology/cytopathology fellowship at Beth Israel Hospital-Harvard Medical School (1989). Her research focuses on diagnostic pathology innovations, immune mechanisms in kidney disease, and viral oncogenesis. Recent work includes studies on polyomavirus immune control, papillomavirus cancer screening, and targeted therapies for adenocarcinomas. Dr. Abendroth has received prestigious awards including the 2023 Dean's Award for Excellence in Teaching and the 2016 Distinguished Educator Award. She actively contributes to policy discussions on telepathology and remote diagnostics through collaborative initiatives with national pathology organizations.

• Dermatopathology
• Skin Cancer
• Melanoma
• +۲ مورد دیگر

Scott R. Florell, MD, is a Professor in the Department of Dermatology at the University of Utah School of Medicine. He specializes in dermatopathology and skin cancer diagnosis, with a focus on melanoma and UV-induced DNA damage. Residency in Dermatology, University of Utah School of Medicine Residency in Pathology, University of Utah School of Medicine MD from University of Nebraska - Omaha B.S. in Biology, University of Nebraska - Lincoln His research spans dermatopathology, skin cancer epidemiology, and chemoprevention strategies. Recent work examines UV radiation effects on nevi and aspirin's role in DNA damage prevention. Selected trends in his publications (2024-2007) include dermatopathology diagnostics, melanoma progression, UV-induced carcinogenesis, and teledermatology innovations. His collaborations emphasize interdisciplinary approaches in dermatology, pathology, and pharmacology. As a board-certified dermatopathologist, Dr. Florell combines clinical expertise in skin disease diagnosis with educational contributions through research and resident training.